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Neuronal excitability and pace-making in the sinoatrial
node are controlled by low-voltage activated CaV1.3 L-
type Ca2+ channels. We recently found that in related
CaV1.4 channels a highly-structured distal C-terminal
motif (CTM) modulates voltage- and Ca2+-dependent gat-
ing (CDI). In CaV1.3, C-terminal splicing leads to a full-
length (CaV1.3L) and at least 1 short (CaV1.3S) splice
form. If a CTM would also modulate CaV1.3 gating it
would be present in CaV1.3L but not CaV1.3S variants. We
therefore compared the biophysical properties of CaV1.3L
or CaV1.3S coexpressed with β3 + α2δ-1 in tsA-201 cells
using the whole-cell patch-clamp technique. CaV1.3S
channels activated at more negative potentials compared
to CaV1.3L (~ -10 mV, p < 0.0001), inactivated faster (p <
0.01) and showed more CDI (p < 0.01). These changes
resulted in a decreased window current shifted to more
hyperpolarized potentials likely to cause a reduction in
the channels' dynamic range. Removal of the C-terminal
158 (CaV1.3Δ1158) or 76 amino acids was sufficient to
induce gating properties similar to CaV1.3S. FRET experi-
ments revealed interaction of the last 158 amino acids
(C158) to a proximal C-terminal domain in CaV1.3L. Coex-
pression of C158 with CaV1.3Δ1158 completely restored
CaV1.3L gating properties confirming this protein interac-
tion. Thus CaV1.3 channel gating is under control of the
distal C-terminus allowing alternative splicing to fine-
tune channel activity and adapt channel function to phys-
iological needs.
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